Idiopathic Inflammatory Myopathies Clinical Trials in Toulouse
3 recruitingToulouse, France
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Rheumatoid ArthritisSystemic Lupus ErythematosusIdiopathic Inflammatory Myopathies
AstraZeneca72 enrolled35 locationsNCT06916806
Recruiting
Phase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Systemic Sclerosis (SSc)Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)
Artiva Biotherapeutics, Inc.90 enrolled26 locationsNCT06991114
Recruiting
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
Idiopathic Inflammatory MyopathiesGiant Cell ArteritisPolymyalgia Rheumatica+1 more
University Hospital, Brest300 enrolled11 locationsNCT04664465